Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Virology Vol. 87; no. 8; pp. 4176 - 4184
Main Authors: Seema Mittal, Rajinthna M. Bandaranayake, Nancy M. King, Moses Prabu-Jeyabalan, Madhavi N. L. Nalam, Ellen A. Nalivaika, Nese Kurt Yilmaz, Celia A. Schiffer
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 01-04-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList Drug resistance occurs through a series of subtle changes that maintain substrate recognition but no longer permit inhibitor binding. In HIV-1 protease, mutations at I50 are associated with such subtle changes that confer differential resistance to specific inhibitors. Residue I50 is located at the protease flap tips, closing the active site upon ligand binding. Under selective drug pressure, I50V/L substitutions emerge in patients, compromising drug susceptibility and leading to treatment failure. The I50V substitution is often associated with amprenavir (APV) and darunavir (DRV) resistance, while the I50L substitution is observed in patients failing atazanavir (ATV) therapy. To explain how APV, DRV, and ATV susceptibility are influenced by mutations at residue 50 in HIV-1 protease, structural and binding thermodynamics studies were carried out on I50V/L-substituted protease variants in the compensatory mutation A71V background. Reduced affinity to both I50V/A71V and I50L/A71V double mutants is largely due to decreased binding entropy, which is compensated for by enhanced enthalpy for ATV binding to I50V variants and APV binding to I50L variants, leading to hypersusceptibility in these two cases. Analysis of the crystal structures showed that the substitutions at residue 50 affect how APV, DRV, and ATV bind the protease with altered van der Waals interactions and that the selection of I50V versus I50L is greatly influenced by the chemical moieties at the P1 position for APV/DRV and the P2 position for ATV. Thus, the varied inhibitor susceptibilities of I50V/L protease variants are largely a direct consequence of the interdependent changes in protease inhibitor interactions.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Author Rajinthna M. Bandaranayake
Ellen A. Nalivaika
Nese Kurt Yilmaz
Seema Mittal
Celia A. Schiffer
Madhavi N. L. Nalam
Nancy M. King
Moses Prabu-Jeyabalan
Author_xml – sequence: 1
  fullname: Seema Mittal
– sequence: 2
  fullname: Rajinthna M. Bandaranayake
– sequence: 3
  fullname: Nancy M. King
– sequence: 4
  fullname: Moses Prabu-Jeyabalan
– sequence: 5
  fullname: Madhavi N. L. Nalam
– sequence: 6
  fullname: Ellen A. Nalivaika
– sequence: 7
  fullname: Nese Kurt Yilmaz
– sequence: 8
  fullname: Celia A. Schiffer
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23365446$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1vFDEMhiNURLeFG2cU7kwb52uyF6Rt-eiiIhCUilvkzWQ6qTqZVZLZqr32jzPsQgUn2_Lj17LfA7IXh-gJeQnsCICb40-XyyMmpNEV8CdkBmxuKqVA7pEZY5xXSpif--Qg52vGQEotn5F9LoRWUz4jD99LGl0ZE95QjA296Hzqh-YuYh8cPcEcMh1auujXyUfchHT8DtO4zbb8ouA97spvfoILRudpiPRseVkB_ZqG4jF7ehtKRz-PBUsYYqZYtngzeqrYc_K0xZvsX_yJh-THh_cXp2fV-ZePy9PFeeWkqEvVTNdK5eRcGs61NmpV12beYgtGMCOB1Y3TDVeI4J1Q7WrloRHAwXjNPTpxSN7udNfjqveN87FMZ9t1Cj2mOztgsP93Yujs1bCxQnMpNJsE3uwEXBpyTr59nAVmf5thJzPs1gwLfMJf_bvvEf77_Ql4vQO6cNXdhuQt5t5eb4I1tTVWQq3FL35DlEo
CitedBy_id crossref_primary_10_3389_fmicb_2016_00061
crossref_primary_10_1080_07391102_2015_1018326
crossref_primary_10_1021_acs_biochem_9b00446
crossref_primary_10_1016_j_cplett_2018_06_040
crossref_primary_10_1073_pnas_1414063111
crossref_primary_10_1002_prot_24730
crossref_primary_10_1021_acs_jcim_5b00667
crossref_primary_10_7554_eLife_80328
crossref_primary_10_3390_molecules26030611
crossref_primary_10_1016_j_compbiomed_2022_105523
crossref_primary_10_1021_acs_jctc_9b00781
crossref_primary_10_1038_s41598_024_53940_1
crossref_primary_10_1002_jcc_27298
crossref_primary_10_1021_acsinfecdis_8b00336
crossref_primary_10_1039_C6RA09201B
crossref_primary_10_1039_D1CP05075C
crossref_primary_10_1016_j_tim_2016_03_010
crossref_primary_10_1021_acs_jctc_7b00601
crossref_primary_10_1021_acs_jcim_5b00173
crossref_primary_10_1021_acs_jctc_7b01109
Cites_doi 10.1097/00002030-199912030-00006
10.1128/AAC.00574-10
10.1093/nar/gkg100
10.1007/978-1-4612-3374-9_13
10.1107/S0907444994003112
10.1021/jm049560p
10.1128/JVI.02531-09
10.1128/JVI.80.7.3607-3616.2006
10.1007/978-1-4615-5373-1_2
10.1345/aph.10423
10.1128/JVI.02706-06
10.1089/aid.1992.8.153
10.1128/jvi.69.9.5228-5235.1995
10.2217/17469600.1.3.291
10.1111/j.1747-0285.2008.00647.x
10.1128/AAC.01540-10
10.1016/S0021-9258(19)50290-3
10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R
10.1016/j.jviromet.2007.05.009
10.1128/AAC.49.9.3825-3832.2005
10.1021/bi2018317
10.1128/JVI.78.22.12446-12454.2004
10.1021/ct9004678
10.1128/AAC.44.8.2093-2099.2000
10.1016/S0969-2126(02)00720-7
10.1086/386291
10.1007/978-1-4757-9209-6_30
10.1128/JVI.78.21.12012-12021.2004
10.1016/S0076-6879(97)76066-X
10.1107/S0907444906005270
10.1110/ps.25502
10.1107/S0907444904019158
10.1038/374569a0
10.1021/jp2074804
10.1111/j.1742-4658.2010.07771.x
ContentType Journal Article
Copyright Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
Copyright_xml – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1128/JVI.03486-12
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 4184
ExternalDocumentID 10_1128_JVI_03486_12
23365446
jvi_87_8_4176
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIH HHS
  grantid: S10 OD012028
– fundername: NIGMS NIH HHS
  grantid: P01-GM66524
– fundername: NCRR NIH HHS
  grantid: RR007707
– fundername: NCRR NIH HHS
  grantid: P41 RR007707
– fundername: NIGMS NIH HHS
  grantid: P01 GM066524
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAYJJ
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
D0S
DIK
E3Z
EBS
ECM
EIF
EJD
F20
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
NPM
O9-
OHT
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c437t-d12845c4948226685b7789faf183084107dc6d25aa1ec35fbbe1d31218e62eac3
IEDL.DBID RPM
ISSN 0022-538X
IngestDate Tue Sep 17 21:12:36 EDT 2024
Thu Nov 21 22:03:38 EST 2024
Sat Sep 28 08:39:49 EDT 2024
Wed May 18 15:26:13 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c437t-d12845c4948226685b7789faf183084107dc6d25aa1ec35fbbe1d31218e62eac3
Notes S.M., R.M.B., and N.M.K. contributed equally to this article.
Present address: Rajinthna M. Bandaranayake, Skirball Institute, New York University Medical School, New York, New York, USA; Moses Prabu-Jeyabalan, Department of Molecular Biology, The Commonwealth Medical, College, Scranton, Pennsylvania, USA.
OpenAccessLink https://jvi.asm.org/content/jvi/87/8/4176.full.pdf
PMID 23365446
PageCount 9
ParticipantIDs crossref_primary_10_1128_JVI_03486_12
pubmed_primary_23365446
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3624360
highwire_asm_jvi_87_8_4176
PublicationCentury 2000
PublicationDate 2013-04-01
PublicationDateYYYYMMDD 2013-04-01
PublicationDate_xml – month: 04
  year: 2013
  text: 2013-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2013
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
Tisdale M (e_1_3_2_13_2) 1999
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
Colonno R (e_1_3_2_16_2) 2004
Van Marck H (e_1_3_2_14_2) 2007; 12
Elston R (e_1_3_2_37_2) 2006; 11
e_1_3_2_9_2
e_1_3_2_15_2
DeLano WL (e_1_3_2_30_2) 2002
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_35_2
Roberts NA (e_1_3_2_5_2) 1995; 9
Henderson LE (e_1_3_2_7_2) 1988
References_xml – ident: e_1_3_2_19_2
  doi: 10.1097/00002030-199912030-00006
– ident: e_1_3_2_32_2
  doi: 10.1128/AAC.00574-10
– ident: e_1_3_2_18_2
  doi: 10.1093/nar/gkg100
– volume: 11
  start-page: S102
  year: 2006
  ident: e_1_3_2_37_2
  article-title: De-selection for the I50V mutation occurs in clinical isolates during Aptivus/r (tipranavir/ritonavir) based therapy
  publication-title: Antivir. Ther.
  contributor:
    fullname: Elston R
– ident: e_1_3_2_28_2
  doi: 10.1007/978-1-4612-3374-9_13
– volume-title: Abstr. Conf. Retroviruses Opportunistic Infect.
  year: 2004
  ident: e_1_3_2_16_2
  contributor:
    fullname: Colonno R
– ident: e_1_3_2_25_2
  doi: 10.1107/S0907444994003112
– ident: e_1_3_2_35_2
  doi: 10.1021/jm049560p
– ident: e_1_3_2_31_2
  doi: 10.1128/JVI.02531-09
– ident: e_1_3_2_26_2
  doi: 10.1128/JVI.80.7.3607-3616.2006
– ident: e_1_3_2_8_2
  doi: 10.1007/978-1-4615-5373-1_2
– ident: e_1_3_2_9_2
  doi: 10.1345/aph.10423
– ident: e_1_3_2_33_2
  doi: 10.1128/JVI.02706-06
– volume: 9
  start-page: S27
  year: 1995
  ident: e_1_3_2_5_2
  article-title: Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors
  publication-title: AIDS
  contributor:
    fullname: Roberts NA
– ident: e_1_3_2_2_2
  doi: 10.1089/aid.1992.8.153
– ident: e_1_3_2_12_2
  doi: 10.1128/jvi.69.9.5228-5235.1995
– ident: e_1_3_2_38_2
  doi: 10.2217/17469600.1.3.291
– ident: e_1_3_2_39_2
  doi: 10.1111/j.1747-0285.2008.00647.x
– ident: e_1_3_2_42_2
  doi: 10.1128/AAC.01540-10
– ident: e_1_3_2_22_2
  doi: 10.1016/S0021-9258(19)50290-3
– ident: e_1_3_2_6_2
  doi: 10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R
– ident: e_1_3_2_15_2
  doi: 10.1016/j.jviromet.2007.05.009
– ident: e_1_3_2_34_2
  doi: 10.1128/AAC.49.9.3825-3832.2005
– ident: e_1_3_2_40_2
  doi: 10.1021/bi2018317
– ident: e_1_3_2_21_2
  doi: 10.1128/JVI.78.22.12446-12454.2004
– volume-title: Abstr. Sixth Conf. Retroviruses Opportunistic Infect.
  year: 1999
  ident: e_1_3_2_13_2
  contributor:
    fullname: Tisdale M
– ident: e_1_3_2_41_2
  doi: 10.1021/ct9004678
– ident: e_1_3_2_11_2
  doi: 10.1128/AAC.44.8.2093-2099.2000
– ident: e_1_3_2_43_2
  doi: 10.1016/S0969-2126(02)00720-7
– ident: e_1_3_2_17_2
  doi: 10.1086/386291
– ident: e_1_3_2_4_2
  doi: 10.1007/978-1-4757-9209-6_30
– volume: 12
  start-page: S141
  year: 2007
  ident: e_1_3_2_14_2
  article-title: Unraveling the complex resistance pathways of darunavir using the bioinformatics resistance determination (BIRD)
  publication-title: Antivir. Ther.
  contributor:
    fullname: Van Marck H
– ident: e_1_3_2_10_2
  doi: 10.1128/JVI.78.21.12012-12021.2004
– ident: e_1_3_2_24_2
  doi: 10.1016/S0076-6879(97)76066-X
– volume-title: Human retroviruses, cancer and AIDS: approaches to prevention and therapy.
  year: 1988
  ident: e_1_3_2_7_2
  contributor:
    fullname: Henderson LE
– ident: e_1_3_2_27_2
  doi: 10.1107/S0907444906005270
– ident: e_1_3_2_23_2
  doi: 10.1110/ps.25502
– ident: e_1_3_2_29_2
  doi: 10.1107/S0907444904019158
– ident: e_1_3_2_3_2
  doi: 10.1038/374569a0
– ident: e_1_3_2_20_2
  doi: 10.1021/jp2074804
– volume-title: The PyMol molecular graphics system.
  year: 2002
  ident: e_1_3_2_30_2
  contributor:
    fullname: DeLano WL
– ident: e_1_3_2_36_2
  doi: 10.1111/j.1742-4658.2010.07771.x
SSID ssj0014464
Score 2.2629354
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Drug resistance occurs through a series of subtle changes that maintain substrate recognition but no longer permit inhibitor binding. In HIV-1 protease,...
SourceID pubmedcentral
crossref
pubmed
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4176
SubjectTerms Anti-HIV Agents - pharmacology
Atazanavir Sulfate
Carbamates - pharmacology
Crystallography, X-Ray
Darunavir
Drug Resistance, Viral
HIV Protease - chemistry
HIV Protease - genetics
HIV-1 - drug effects
HIV-1 - genetics
Humans
Kinetics
Models, Molecular
Mutant Proteins - chemistry
Mutant Proteins - genetics
Mutation, Missense
Oligopeptides - pharmacology
Point Mutation
Protein Binding
Protein Conformation
Pyridines - pharmacology
Sulfonamides - pharmacology
Thermodynamics
Vaccines and Antiviral Agents
Title Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50
URI http://jvi.asm.org/content/87/8/4176.abstract
https://www.ncbi.nlm.nih.gov/pubmed/23365446
https://pubmed.ncbi.nlm.nih.gov/PMC3624360
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZYJKReqgJ9LAXkAz1mk_iReI_LSwsSFSot4mb5FTVVk0WbXaT2yh9n7KzR7pVbojhRlG_smcmMvw-hE6Ist74-OKbOS5g5l2hRFEmpiOHgb7Vhfu_w9K78_iDOLzxNDo97YULTvtH1qP3bjNr6d-itfGxMGvvE0tubM1h0GS2ydIAGEBvGFH1VOoD8hkWKcJjND7HbnYj0-v5qlFEmvPKMZwGmtODMh77rLinSBK-5pM12yTX_c_kBvV8FjnjSv-Au2nLtHtrppST_7aPnu0AE60k0sGotBvjnzcz2evP4VHV1h2cVnjSew1I91fP0XM2X4SiMnyzUf9Wf_nCdDyrBGnDd4unVfZLjW0_nAA4P-_-2-GbZF_A7rBZhuF06zLOP6Nflxc-zabISWEgMo-Uisd45ceMZYiAKKwTXZSnGlapgnmeCQWZoTWEJVyp3hvJKa5dbmkNU4AoCKzb9hLbbWeu-IOx1rTI1thpWUMbpWAuTO0KU01orllVD9C1-Y_nY82jIkH8QIQEWGWCRORmigwiAVF0j_zzVUpRSSJaXxRB97pF4fUSEcIjKDYxeB3j27M0rYFSBRXtlRAdvvvMrekeCNoZv4zlE2wCzO0KDzi6Pg0W-AFjO5fc
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB00KYrm0n1xuvHQHmVJXCT66GaB3cZB0KRBbgQ3oSoiObDsAO21P16SMgP7mpsEUoKAR86iGb4H8BlLw4yvD46I9RJm1iaKF0VSSqyZ87dKU392eHJenl7xwyNPk8PiWZjQtK9VPWyvm2Fb_wq9lTeNTmOfWHo2O3BGl5IiS3fgoduvWRaT9HXxwGU4NJKEu_Gr2O-OefrtcjrMCOVee8bzABNSMOqD302nFImCN5zSdsPkhgc6fnrPb38GT9YhJxr3w8_hgW1fwKNehPLPS_h3HihkPf0Gkq1BbuEsmrnplerRV9nVHZpXaNx49kt5Wy_SQ7lYhaswf7yUf2V_-8N2Phx16wjVLZpML5McnXkiCOcqkf_ji2arvvTfIbkM083KIpa9gp_HRxcHk2QtzZBoSsplYrxbY9pzy7j4reBMlSUfVbJyFiLj1OWURhcGMylzqwmrlLK5IbmLJ2yBna0nr2G3nbf2LSCviJXJkVHO9lJGRorr3GIsrVJK0qwawJeIjbjpGThEyFwwFw5OEeAUOR7AfgROyK4Rv29rwUvBBc3LYgBvegTvXhGhH0C5he3dBM-7vT3iIA3822sI9-_95Cd4PLmYnYiT6en3d7CHg8KGbwZ6D7sOcvsBdjqz-hhW9X_FVvt3
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9NAFH6iRSAu7EtaCnOAo2N7FntyTJtGCdAqolD1NprNwgg7UZxUgit_nJlxHCXXcrM1z5al7_ktnufvA_iApWHG7w8OiPUSZtZGimdZlEusmcu3SlP_7_DkKr-84aNzT5OzlfoKQ_talf36V9Wvyx9htnJR6bibE4tnF2cu6FKSJfHCFPEB3HfvbIK7Rn2zgeC6HNoRhbv1m27mHfP40_W0nxDKvf6M5wImJGPUF8C7iakjC95JTPtDkztZaPzkP57_KTzelJ5o2Jo8g3u2fg4PWjHK3y_g71WgkvU0HEjWBjkHWlZz0yrWo1PZlA2aF2hYeRZMeVsu45FcrsNRsB-u5B_Znn61jS9LnT-hskaT6XWUopknhHApE_kvv-hi3Y4ANEiugrlZW8SSl_B9fP7tbBJtJBoiTUm-ioxPb0x7jhlXx2WcqTzng0IWLlIknLre0ujMYCZlajVhhVI2NSR1dYXNsIv55BUc1vPavgHklbESOTDKxWDKyEBxnVqMpVVKSZoUPfjY4SMWLROHCB0M5sJBKgKkIsU9OOrAE7KpxM_bUvBccEHTPOvB6xbF7S06-HuQ7-G7NfD82_srDtbAw72B8ejOV76Hh7PRWHyZXn4-hkc4CG34maC3cOgQtydw0Jj1u-DY_wC4Z_33
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+and+Thermodynamic+Basis+of+Amprenavir%2FDarunavir+and+Atazanavir+Resistance+in+HIV-1+Protease+with+Mutations+at+Residue+50&rft.jtitle=Journal+of+virology&rft.au=Mittal%2C+Seema&rft.au=Bandaranayake%2C+Rajinthna+M.&rft.au=King%2C+Nancy+M.&rft.au=Prabu-Jeyabalan%2C+Moses&rft.date=2013-04-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=8&rft.spage=4176&rft.epage=4184&rft_id=info:doi/10.1128%2FJVI.03486-12&rft_id=info%3Apmid%2F23365446&rft.externalDBID=PMC3624360
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon